María Rosa BONO Ph.D. Professor Faculty of Sciences
(
www.uchile.cl/facultades/ciencias). Universidad de Chile.
Dr. Bono, a renowned Chilean immunologist begun undergraduate studies in Chemistry at the Faculty of Science, University of Chile. In 1974 she traveled to France where she obtained a "Maîtrisse in Physical Chemistry" at the Faculty of Sciences, University of Paris. Pursuing her studies she became increasingly interested in Biology and in 1978, she gained a post-doctoral fellowship intended to support graduate students wishing to "convert" to Biology. This fellowship gave her the opportunity to work in the laboratory of Nobel Laureate Jean Dausset, obtaining a "Diplôme in Immunology" at the Pasteur Institute. Since then she has continue to work in histocompatibility molecules. As a postdoctoral Fellow at Dr. Jack Strominger 's lab at Harvard University, she discobered that human HLA-DR molecules were the equivalent of the mouse I-E and that DC-1 and that HLA-DQ was the equivalent of I-A antigens. In 1983, she returned to France were she obtained a permanent position at the CNRS. Back in France she started research on the mechanism by which IFN-g regulates MHC Class II expression. In 1991 she took a position at the Faculty of Sciences of the University of Chile where she created the Immunology Laboratory and started a vigorous research on immunology. Dr. Bono is the recipient of several international prices.

ACADEMIC POSITIONS: Associate Professor, Faculty of Sciences University of Chile, Invited Professor. Institute Adolfo Lutz, Sao Paulo, Brazil, Invited Profesor. Faculty of Sciences, University of Paris.

PUBLICATIONS: 52 publications in mainstream journals and two book chapters.

SELECTED PUBLICATIONS

BONO, M.R., Reyes, L.I. and M. ROSEMBLATT. "A flow cytometric procedure for the quantification of cell adhesion in complex mixtues of cells". J. Immunol. Meth. 223: 27-36 (1999).

C. Hetz, M.R. BONO, L.F. Barros and R. Lagos. “Microcin E492, a channel forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines”. PNAS 99: 2696-2701 (2002).

R. Naves, A.M. Lennon, G. Barbieri, L. Reyes, G. Puga, L. Salas, V. Deffresnnes, M. ROSEMBLATT, M. Fellous, D. Charron, C. Alacide-Loridan and M.R. BONO. “MHC class-II deficient tumor cell lines with a defective expression of the class-II transactivator (CIITA)”. Int. Immunol., 14: 481-591 (2002).

L. I. Reyes, P. Escobar, M. R. BONO and M. ROSEMBLATT. B Lymphocyte “Adhesion to Endothelial Cells from Human Lymphoid Tissue Modulates Tyrosine Phosphorylation and Endothelial Cell Activation”. J. Immunol. 169: 5881-5888 (2002)

D. Sauma, J.R. Mora, A. Fierro, J. Morales, C. Herzog, E. Buckel, M. ROSEMBLATT and M.R. BONO. “Low-dose prednisone accounts for the marked reduction on CD4+ and CD8+ T cells in renal transplant patients under triple therapy”. Transplantation Proceedings 34: 3183-3184 (2002).

A. Fierro, J.R. Mora, M.R. BONO, J. Morales, E. Buckel, D. Sauma and M. ROSEMBLATT. “Dendritic cells and the mode of action of anticalcineurinic drugs. An integrating hypothesis” Nephrology Dialysis Transplantation. 18: 467-468 (2003).

J.R. Mora, M.R. BONO, N. Manjunath, W. Weninger, L.L. Cavanagh, M. ROSEMBLATT and U. H. von Andrian. “Selective imprinting of gut-homing T cells by Peyer’s patch dendritic cells”. In press, Nature (2003).